Refine by
Genome Sequence Suppliers & Manufacturers
6 companies found
Technologybased inDelhi, INDIA
Premas Life Sciences (PLS) is a young, dynamic, and focused organization introducing game-changing niche technologies in Genomics, Cell Biology, and Biopharma to boost innovative research and diagnostics in India. We are also the knowledge partners ...
The MiniSeq System delivers the power and confidence of proven Illumina next-generation sequencing (NGS) technology in an accessible sequencing solution. It features cost-efficient sequencing, even for low numbers of samples. Its streamlined ...
Technologybased inHørsholm, DENMARK
We are an AI-immunology platform company decoding the human immune system to discover and develop novel immunotherapies for cancer and infectious diseases. We have developed our AI-immunology core technology to deeply understand the biological ...
EDEN is our second AI platform that rapidly identifies novel, highly protective antigens for the use in pathogen-specific prophylactic vaccines against bacteria. EDEN has been designed to rapidly identify those antigens that will trigger a robust ...
Technologybased inParis, FRANCE
Eligo Bioscience is a biotechology company that develops a new class of biotherapeutics for microbiome precision-editing. Eligo Bioscience was created in 2014 by scientists from Rockefeller University and ...
Eligobiotics are a first-in-class proprietary modality that enables the delivery and expression of therapeutic DNA in target bacterial populations of the microbiome. This technology allows modulation of the microbiome’s composition and ...
Technologybased inNorwich, UNITED KINGDOM
We are a passionate and skilled drug discovery and development biotech team developing an innovative new class of oligonucleotide antimicrobial agents. Procarta is currently working on lead optimisation for its first product, a narrow-spectrum agent ...
Proprietary nanoparticles deliver an oligonucleotide inside the bacterial pathogen. The oligonucleotide acts as a Transcription Factor Decoy (TFD): it contains the binding site of a transcription factor that controls a large set of genes required ...
Technologybased inSacramento, CALIFORNIA (USA)
We are a next-generation biotechnology company creating an AI-powered platform for custom protein design. Our platform develops Novobinders: proprietary protein binders with diagnostic and therapeutic applications. AINovo Biotech works with select ...
Technologybased inPhoenix, ARIZONA (USA)
BacVax, Inc., a Delaware corporation with headquarters in Phoenix, Arizona, is developing vaccines against bacteria. BacVax holds an Exclusive Patent License Agreement to use the BVP platform in conjunction with additional patent applications ...
Current commercial bacterial vaccines use toxin neutralization, capsule targeting, or multiple proteins. While these methods may work in some circumstances, many bacteria do not have toxin or capsule targets, and using several proteins in a ...